trial · primary record
Mo-Rez
Tumours, Gynecological
| Phase | Phase 1, Phase 2 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 305 |
| Primary completion | 2028-10-10 |
| Primary endpoint | Part A: Percentage of participants with dose limiting toxicities (DLTs) |
| Registry ID | NCT06796907 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-11-02T15:44:24.787Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT06796907
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.